Kaposi's sarcoma treated with topical alitretinoin;Sarcoma de Kaposi clásico tratado con alitretinoína tópica

Actas Dermo-Sifiliograficas

Volumn 98, Issue 1, 2007, Pages 50-53

  González De Arriba, Ana ^a   Perez Gala S ^a   Goiriz Valdes R ^a   Rios Buceta L ^a   Garcia Diez A ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Alitretinoin; Kaposi's sarcoma

Indexed keywords

ALITRETINOIN; ALPHA2B INTERFERON; METHOTREXATE; PREDNISONE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; EDEMA; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; KAPOSI SARCOMA; LABORATORY TEST; POLYMERASE CHAIN REACTION; SJOEGREN SYNDROME; SKIN BIOPSY; SKIN MANIFESTATION; TREATMENT OUTCOME;

EID: 33947408171     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(07)70010-8     Document Type: Article

References (5)

1. Duvic M, Friedman-Kien E, Looney J, Miles A, Myskowsky L, Scadden DT, et al. Treatments of Cutaneous Lesions of Acquired Immunodeficiency Syndrome-Related Kaposi sarcoma Using Alitretinoin Gel. Results of Phase 1 and 2 trials. Arch Dermatol. 2000;136:1461-9.
2. Bodsworth J, Bloch M, Bower M, Yocum R, The International Panretin gel KS study Group. Phase III Vehicle-controlled, Multi-centered Study of topical Alitretinoin gel 0.1 % in cutaneous AIDS-Related Kaposi's Sarcoma. Am J Dermatol. 2001;2:77-87.
3. Cheer M, Foster H. Alitretinoin. Am J Dermatol. 2001;1: 307-14.
4. Morganroth GS. Topical 0.1 % alitretinoin gel for classic Kaposi Sarcoma. Arch Dermatol. 2002;138:542-3.
5. Aversa SML, Cattelan AM, Salvagno L, Crivellani G, Banna G, Trevendi M, et al. Treatments of AIDS-related Kaposi's Sarcoma. Crit Rev Oncol Hematol. 2005;53:253-65.